Gabapentin Enacarbil XR Efficacy Less Than Expected for AUD Carlat Reports

Gabapentin Enacarbil XR Efficacy Less Than Expected for AUD

The Carlat Addiction Treatment Report, Volume 7, Number 5, August 2019
https://www.thecarlatreport.com/newsletter-issue/catrv7n5/

From The Carlat Addiction Treatment Report, August 2019, Legal Issues in Addiction Medicine

Issue Links: Learning Objectives | Editorial Information

Thomas Jordan, MD

Dr. Jordan has disclosed that he has no relevant financial or other interests in any commercial companies pertaining to this educational activity.

This 2019 randomized, double-blind, placebo- controlled trial study casts doubt on using gabapentin enacarbil extended-release (GE-XR) (Horizant), an extended-release version of gabapentin, for treatment in patients with alcohol use disorder

You can't view details of this content, please login or buy subscription here